COVID-19 (coronavirus)


Image of Covid-19.

June 10

Although most children who are infected with SARS-CoV-2, the virus that causes COVID-19, experience mild symptoms, a very few develop a hyperinflammatory syndrome due to a specific reaction by their immune systems, according to a recent study co-led by Cedars-Sinai.

FDA Approves Lung Drug After NEJM Study

June 10

Patients with interstitial lung disease (ILD) who develop pulmonary hypertension have had few therapeutic options, until now. The Food and Drug Administration (FDA) recently approved inhaled treprostinil for treating these patients after results of a multicenter study co-led by Cedars-Sinai.

Have Questions or Need Help?

Contact us if you have questions or wish to learn more about research at Cedars-Sinai.